We revealed SLC1A5 to be an adverse prognostic factor in KIRC (p = 0.003), LGG (p < 0.001), HCC (p < 0.001), MESO (p < 0.001), and UVM (p = 0.009) (Figure 2). Here, SLC1A5 is linked to hepatocellular carcinoma.